Abstract

Formate is a precursor for the de novo synthesis of purine and deoxythymidine nucleotides. Formate also interacts with energy metabolism by promoting the synthesis of adenine nucleotides. Here we use theoretical modelling together with metabolomics analysis to investigate the link between formate, nucleotide and energy metabolism. We uncover that endogenous or exogenous formate induces a metabolic switch from low to high adenine nucleotide levels, increasing the rate of glycolysis and repressing the AMPK activity. Formate also induces an increase in the pyrimidine precursor orotate and the urea cycle intermediate argininosuccinate, in agreement with the ATP-dependent activities of carbamoyl-phosphate and argininosuccinate synthetase. In vivo data for mouse and human cancers confirms the association between increased formate production, nucleotide and energy metabolism. Finally, the in vitro observations are recapitulated in mice following and intraperitoneal injection of formate. We conclude that formate is a potent regulator of purine, pyrimidine and energy metabolism.

Details

Title
Formate induces a metabolic switch in nucleotide and energy metabolism
Author
Oizel Kristell 1 ; Tait-Mulder, Jacqueline 1 ; Fernandez-de-Cossio-Diaz, Jorge 2 ; Pietzke Matthias 1 ; Brunton, Holly 1 ; Lilla Sergio 1   VIAFID ORCID Logo  ; Dhayade Sandeep 1 ; Athineos Dimitri 1   VIAFID ORCID Logo  ; Blanco Giovanny Rodriguez 1   VIAFID ORCID Logo  ; Sumpton, David 1   VIAFID ORCID Logo  ; Mackay, Gillian M 1 ; Blyth, Karen 1 ; Zanivan, Sara R 3   VIAFID ORCID Logo  ; Meiser, Johannes 4 ; Vazquez, Alexei 3   VIAFID ORCID Logo 

 Cancer Research UK Beatson Institute, Glasgow, UK (GRID:grid.23636.32) (ISNI:0000 0000 8821 5196) 
 Center of Molecular Immunology, Havana, Cuba (GRID:grid.417645.5) (ISNI:0000 0004 0444 3191) 
 Cancer Research UK Beatson Institute, Glasgow, UK (GRID:grid.23636.32) (ISNI:0000 0000 8821 5196); University of Glasgow, Institute of Cancer Sciences, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X) 
 Luxembourg Institute of Health, Department of Oncology, Luxembourg, Luxembourg (GRID:grid.451012.3) (ISNI:0000 0004 0621 531X) 
Publication year
2020
Publication date
May 2020
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2398122990
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.